Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Отечественная и международная практика лечения хламидийной инфекции у беременных с позиции доказательной медицины
Отечественная и международная практика лечения хламидийной инфекции у беременных с позиции доказательной медицины
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Полный текст
Список литературы
1. Global prevalente and incidence of curable STis. World Health Organization, 2001 (WHO/CDC/CDR/EDC/2001.10).
2. Mayand P, Mabey D. Approaches to the control of sexually transmitted infections in developing countries: old problems and modern challenges. Sex Trans Inf 2004; 80: 174–82.
3. Hueston WJ, Lenhart JG. A decision analysis to guige antibiotis selection for Chlamydia infection during pregnancy. Arch Fam Med 1997; 6: 551–5.
4. Centers for disease and prevention. Sexually transmitted disease surveillance 2003 supplement. Atlanta, GA; CDC, 2004.
5. Advanced Fertility Center of Chicago. http://www.advancedfertility.com/ectopic.htm[accessed 9 May 2007].
6. Woman at the Rise of the 21st Centry: Gynecological and Reproductine issues in Health and Diseases. Conference proceadings. Athens, Greece,Vovember 18–21, 1998. Ann NY Acad Sci 2000; 900: 1–446.
7. Grossman JH, Rivein ME, Morrison JC. Diagnosis of Chlamydial infection in pregnant women using the Testpack Chlamydia diagnostic kit. Obstet Gynecol 1991; 77: 801–3.
8. Andrews WN, Goldenferd RL, Mercer B et al. The Preterm Prediction Study: association of second-trimester genitourinary Chlamydia infection with subsequent spontaneous preterm birth. Am J Obstet Gynecol 2000; 183: 662–8 (Abstract).
9. Fiest A, Sydier T, Gebbers SS et al. No association of Chlamydia with abortion. J Soc Med 1999; 92 (5): 237–8.
10. Miller JM, Martin DH. Treatment of Chlamydia trachomatis infections in pregnant women. Drugs 2000; 60 (3): 597–605.
11. Centers for Disease Control and Prevention. Sexyally Transmitted Diseases Treatment Quidelines-2002. MMWR Morb Mortal Wkly Rep 2002; 51: 1–80.
712. Национальные стандарты в здравоохранении: перспективы разработки и внедрения. Врач 2008. Спец. вып: 2–60.
13. Стандарты медицинской помощи больным урогенитальными инфекциями. Врач. 2009; 1: 36–67.
14. Клинические рекомендации. Российское общество дерматовенерологов. Дерматовенерология. Под ред. А.А.Кубановой. М.: ДЭКС-Пресс, 2008.
15. Клинические рекомендации. Акушерство и гинекология. Под ред. В.Н.Серова, Г.Т.Сухих. 3-е изд. М.: ГОЭТАР-Медиа, 2009.
16. Рациональная фармакотерапия в акушерстве, гинекологии и неонатологии. Под ред. В.Н.Серова, Г.Т.Сухих. М.: Литтерра, 2010.
17. Harris RP, Hefland M, Woolf SH et al. Current methods of the us preventive services task force: a revin of the process. Am J Prev Med 2001; 20 (suppl.): 21–35.
18. Andrade SE, Gurwitz JM, Davis RL et al. Prescription drug use in pregnany. Am J Obstet Gynecol 2004; 191: 398–407.
19. Guidelines for the management of sexually transmitted infections, World Health Organization, 2003.
20. Европейские стандарты диагностики и лечения заболеваний, передаваемых половым путем. М.: Медицинская литература, 2003.
21. Center for Disease Control and Prevention. Guidelines for treatment of sexually transmitted diseases. MMWR 2006.
22. http://www.iusti.org Draft European (IUSTI/WHO) for the management of Chlamydia trachomatis infections.
23. Czeizel AE, Rockenbauer M, Olsen J, Sorensen HT. A case-control teratological study of spiramycin, roxitromycin, oleandomycin and josamycin. Acta Gynecol Scand 2000; 79: 234–7.
24. Solitz-Szots J, Schneider S, Niebauer B et al. [Significance of the dose of josamycin in the treatment of chlamydia infected pregnant patients]. Z Hautkr 1989; 64: 129–31.
25. Седых Н.Н. Этические гарантии доказанности клинических испытаний. Биоэтика. 2008; 1: 16–21.
26. Heikkinen T, Laine K, Neuvonen PJ, Ekblad U. The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. BJOG 2000; 107: 770–5.
27. McCormack WM, George H, Donner A. Hepatotoxicity of erythromycin estolate during pregnancy. AntiMicrob Agents Chemother 1977; 12: 630–5.
28. Kallen BAJ, Otterblad Olausson P, Danielsson BR. Is erythromycin therapy teratogenic in humans? Reprod Toxicol 2005; 20: 209–14.
29. Volberg WA, Koci BJ, Su W et al. Blockade of human cardias potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics. J Pharmacol Exp Ther 2002; 302: 320–7.
30. Dylewski J, Clecner B, Dubois J et al. Comparison of spiramycin and doxycycline for treatment of Chlamydia trachomatis genital infections. Antimicrob Agents Chemother 1993; 37 (6): 1373–4.
31. Fedele L, Acaia B, Marchini M et al. Treatment of Chlamydia trachomatis endometritis with josamycin. J Chemother 1989; 1 (4 Suppl.): 911–2.
32. Решетников О.В., Хрянин А.А. Макролиды в лечении хламидийной инфекции у беременных (эффективность, безопасность, экономичность). Рус. мед. журн. 2008; 16: 23–7.
33. Khrianin AA, Reshetnikov OV. Is it safe to use josamycin in the obstetrics practice in Russia? Antibiot Khimioter 2007; 52: 32–6.
34. Charles P, Stumpf P, Buffet P et al. Two unusual glandular presentations of tick-borne tularemia. Med Mal Infect 2008; 8: 159–61.
35. Юрьев С.Ю., Евтушенко И.Д., Огородова Л.М. Определение концентрации азитромицина в хориальной ткани в I триместре беременности. Антибиот. и химиотер. 2004; 49: 10–2.
36. Ramsey PS, Vaules MB, Vasdev GM et al. Maternal and transplacental pharmacokinetics of azithromycin. Am J Obstet Gynecol 2003; 188: 714–8.
37. Jacobson GF, Autry AM, Kirby RS et al. A randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy. Am J Obstet Gynecol 2001; 184: 1352–4.
38. Edwards MS, Newman RB, Carter SG et al. Randomized clinical trial of azithromycin vs erythromycin for the treatment of Chlamydia cervicitis in pregnancy. Infect Dis Obstet Cynecol 1997; 4: 333–7.
39. Sarkar M, Woodland CC, Koren G, Einarson ARN. Pregnancy outcome following gestational exposure to azithromycin. BMC Pregnancy Childbirth 2006; 6: 18.
40. Brockleburst P, Rooney G. Interventions for treating genital Chlamydia trachomatis infection in pregnancy (Cocbrane Review). In: The Cocbrane Library, Issue 3, 2004. Chicbester, UK: John Wiley & Sons, Ltd.
41. Miller JM, Martin DH. Treatment of Chlamydia trachomatis infections in pregnant women. Drugs 2000; 60 (3): 597–605.
42. Kacmar J, Cheh E, Montagno A, Peipert JF. A randomized trial of azithromycin versus amoxicillin for the treatment of Chlamydia trachomatis in pregnancy. Infect Dis Obstet Gynecol 2001; 9: 197–202.
43. Gunter ME, Adair CD, Ernest JM, McElroy G. Azithromycin powder versus erythromycin in the treatment of chlamydial cervicitis in pregnancy. Infect Dis Obstet Gynecol 1996; 4: 53.
44. Adair CD, Gunter M, Stovall TG et al. Chlamydia in pregnancy: a randomized trial of azithromycin and erythromycin. Obstet Gynecol 1998; 91: 165–8.
2. Mayand P, Mabey D. Approaches to the control of sexually transmitted infections in developing countries: old problems and modern challenges. Sex Trans Inf 2004; 80: 174–82.
3. Hueston WJ, Lenhart JG. A decision analysis to guige antibiotis selection for Chlamydia infection during pregnancy. Arch Fam Med 1997; 6: 551–5.
4. Centers for disease and prevention. Sexually transmitted disease surveillance 2003 supplement. Atlanta, GA; CDC, 2004.
5. Advanced Fertility Center of Chicago. http://www.advancedfertility.com/ectopic.htm[accessed 9 May 2007].
6. Woman at the Rise of the 21st Centry: Gynecological and Reproductine issues in Health and Diseases. Conference proceadings. Athens, Greece,Vovember 18–21, 1998. Ann NY Acad Sci 2000; 900: 1–446.
7. Grossman JH, Rivein ME, Morrison JC. Diagnosis of Chlamydial infection in pregnant women using the Testpack Chlamydia diagnostic kit. Obstet Gynecol 1991; 77: 801–3.
8. Andrews WN, Goldenferd RL, Mercer B et al. The Preterm Prediction Study: association of second-trimester genitourinary Chlamydia infection with subsequent spontaneous preterm birth. Am J Obstet Gynecol 2000; 183: 662–8 (Abstract).
9. Fiest A, Sydier T, Gebbers SS et al. No association of Chlamydia with abortion. J Soc Med 1999; 92 (5): 237–8.
10. Miller JM, Martin DH. Treatment of Chlamydia trachomatis infections in pregnant women. Drugs 2000; 60 (3): 597–605.
11. Centers for Disease Control and Prevention. Sexyally Transmitted Diseases Treatment Quidelines-2002. MMWR Morb Mortal Wkly Rep 2002; 51: 1–80.
712. Национальные стандарты в здравоохранении: перспективы разработки и внедрения. Врач 2008. Спец. вып: 2–60.
13. Стандарты медицинской помощи больным урогенитальными инфекциями. Врач. 2009; 1: 36–67.
14. Клинические рекомендации. Российское общество дерматовенерологов. Дерматовенерология. Под ред. А.А.Кубановой. М.: ДЭКС-Пресс, 2008.
15. Клинические рекомендации. Акушерство и гинекология. Под ред. В.Н.Серова, Г.Т.Сухих. 3-е изд. М.: ГОЭТАР-Медиа, 2009.
16. Рациональная фармакотерапия в акушерстве, гинекологии и неонатологии. Под ред. В.Н.Серова, Г.Т.Сухих. М.: Литтерра, 2010.
17. Harris RP, Hefland M, Woolf SH et al. Current methods of the us preventive services task force: a revin of the process. Am J Prev Med 2001; 20 (suppl.): 21–35.
18. Andrade SE, Gurwitz JM, Davis RL et al. Prescription drug use in pregnany. Am J Obstet Gynecol 2004; 191: 398–407.
19. Guidelines for the management of sexually transmitted infections, World Health Organization, 2003.
20. Европейские стандарты диагностики и лечения заболеваний, передаваемых половым путем. М.: Медицинская литература, 2003.
21. Center for Disease Control and Prevention. Guidelines for treatment of sexually transmitted diseases. MMWR 2006.
22. http://www.iusti.org Draft European (IUSTI/WHO) for the management of Chlamydia trachomatis infections.
23. Czeizel AE, Rockenbauer M, Olsen J, Sorensen HT. A case-control teratological study of spiramycin, roxitromycin, oleandomycin and josamycin. Acta Gynecol Scand 2000; 79: 234–7.
24. Solitz-Szots J, Schneider S, Niebauer B et al. [Significance of the dose of josamycin in the treatment of chlamydia infected pregnant patients]. Z Hautkr 1989; 64: 129–31.
25. Седых Н.Н. Этические гарантии доказанности клинических испытаний. Биоэтика. 2008; 1: 16–21.
26. Heikkinen T, Laine K, Neuvonen PJ, Ekblad U. The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. BJOG 2000; 107: 770–5.
27. McCormack WM, George H, Donner A. Hepatotoxicity of erythromycin estolate during pregnancy. AntiMicrob Agents Chemother 1977; 12: 630–5.
28. Kallen BAJ, Otterblad Olausson P, Danielsson BR. Is erythromycin therapy teratogenic in humans? Reprod Toxicol 2005; 20: 209–14.
29. Volberg WA, Koci BJ, Su W et al. Blockade of human cardias potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics. J Pharmacol Exp Ther 2002; 302: 320–7.
30. Dylewski J, Clecner B, Dubois J et al. Comparison of spiramycin and doxycycline for treatment of Chlamydia trachomatis genital infections. Antimicrob Agents Chemother 1993; 37 (6): 1373–4.
31. Fedele L, Acaia B, Marchini M et al. Treatment of Chlamydia trachomatis endometritis with josamycin. J Chemother 1989; 1 (4 Suppl.): 911–2.
32. Решетников О.В., Хрянин А.А. Макролиды в лечении хламидийной инфекции у беременных (эффективность, безопасность, экономичность). Рус. мед. журн. 2008; 16: 23–7.
33. Khrianin AA, Reshetnikov OV. Is it safe to use josamycin in the obstetrics practice in Russia? Antibiot Khimioter 2007; 52: 32–6.
34. Charles P, Stumpf P, Buffet P et al. Two unusual glandular presentations of tick-borne tularemia. Med Mal Infect 2008; 8: 159–61.
35. Юрьев С.Ю., Евтушенко И.Д., Огородова Л.М. Определение концентрации азитромицина в хориальной ткани в I триместре беременности. Антибиот. и химиотер. 2004; 49: 10–2.
36. Ramsey PS, Vaules MB, Vasdev GM et al. Maternal and transplacental pharmacokinetics of azithromycin. Am J Obstet Gynecol 2003; 188: 714–8.
37. Jacobson GF, Autry AM, Kirby RS et al. A randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy. Am J Obstet Gynecol 2001; 184: 1352–4.
38. Edwards MS, Newman RB, Carter SG et al. Randomized clinical trial of azithromycin vs erythromycin for the treatment of Chlamydia cervicitis in pregnancy. Infect Dis Obstet Cynecol 1997; 4: 333–7.
39. Sarkar M, Woodland CC, Koren G, Einarson ARN. Pregnancy outcome following gestational exposure to azithromycin. BMC Pregnancy Childbirth 2006; 6: 18.
40. Brockleburst P, Rooney G. Interventions for treating genital Chlamydia trachomatis infection in pregnancy (Cocbrane Review). In: The Cocbrane Library, Issue 3, 2004. Chicbester, UK: John Wiley & Sons, Ltd.
41. Miller JM, Martin DH. Treatment of Chlamydia trachomatis infections in pregnant women. Drugs 2000; 60 (3): 597–605.
42. Kacmar J, Cheh E, Montagno A, Peipert JF. A randomized trial of azithromycin versus amoxicillin for the treatment of Chlamydia trachomatis in pregnancy. Infect Dis Obstet Gynecol 2001; 9: 197–202.
43. Gunter ME, Adair CD, Ernest JM, McElroy G. Azithromycin powder versus erythromycin in the treatment of chlamydial cervicitis in pregnancy. Infect Dis Obstet Gynecol 1996; 4: 53.
44. Adair CD, Gunter M, Stovall TG et al. Chlamydia in pregnancy: a randomized trial of azithromycin and erythromycin. Obstet Gynecol 1998; 91: 165–8.
2. Mayand P, Mabey D. Approaches to the control of sexually transmitted infections in developing countries: old problems and modern challenges. Sex Trans Inf 2004; 80: 174–82.
3. Hueston WJ, Lenhart JG. A decision analysis to guige antibiotis selection for Chlamydia infection during pregnancy. Arch Fam Med 1997; 6: 551–5.
4. Centers for disease and prevention. Sexually transmitted disease surveillance 2003 supplement. Atlanta, GA; CDC, 2004.
5. Advanced Fertility Center of Chicago. http://www.advancedfertility.com/ectopic.htm[accessed 9 May 2007].
6. Woman at the Rise of the 21st Centry: Gynecological and Reproductine issues in Health and Diseases. Conference proceadings. Athens, Greece,Vovember 18–21, 1998. Ann NY Acad Sci 2000; 900: 1–446.
7. Grossman JH, Rivein ME, Morrison JC. Diagnosis of Chlamydial infection in pregnant women using the Testpack Chlamydia diagnostic kit. Obstet Gynecol 1991; 77: 801–3.
8. Andrews WN, Goldenferd RL, Mercer B et al. The Preterm Prediction Study: association of second-trimester genitourinary Chlamydia infection with subsequent spontaneous preterm birth. Am J Obstet Gynecol 2000; 183: 662–8 (Abstract).
9. Fiest A, Sydier T, Gebbers SS et al. No association of Chlamydia with abortion. J Soc Med 1999; 92 (5): 237–8.
10. Miller JM, Martin DH. Treatment of Chlamydia trachomatis infections in pregnant women. Drugs 2000; 60 (3): 597–605.
11. Centers for Disease Control and Prevention. Sexyally Transmitted Diseases Treatment Quidelines-2002. MMWR Morb Mortal Wkly Rep 2002; 51: 1–80.
712. Национальные стандарты в здравоохранении: перспективы разработки и внедрения. Врач 2008. Спец. вып: 2–60.
13. Стандарты медицинской помощи больным урогенитальными инфекциями. Врач. 2009; 1: 36–67.
14. Клинические рекомендации. Российское общество дерматовенерологов. Дерматовенерология. Под ред. А.А.Кубановой. М.: ДЭКС-Пресс, 2008.
15. Клинические рекомендации. Акушерство и гинекология. Под ред. В.Н.Серова, Г.Т.Сухих. 3-е изд. М.: ГОЭТАР-Медиа, 2009.
16. Рациональная фармакотерапия в акушерстве, гинекологии и неонатологии. Под ред. В.Н.Серова, Г.Т.Сухих. М.: Литтерра, 2010.
17. Harris RP, Hefland M, Woolf SH et al. Current methods of the us preventive services task force: a revin of the process. Am J Prev Med 2001; 20 (suppl.): 21–35.
18. Andrade SE, Gurwitz JM, Davis RL et al. Prescription drug use in pregnany. Am J Obstet Gynecol 2004; 191: 398–407.
19. Guidelines for the management of sexually transmitted infections, World Health Organization, 2003.
20. Европейские стандарты диагностики и лечения заболеваний, передаваемых половым путем. М.: Медицинская литература, 2003.
21. Center for Disease Control and Prevention. Guidelines for treatment of sexually transmitted diseases. MMWR 2006.
22. http://www.iusti.org Draft European (IUSTI/WHO) for the management of Chlamydia trachomatis infections.
23. Czeizel AE, Rockenbauer M, Olsen J, Sorensen HT. A case-control teratological study of spiramycin, roxitromycin, oleandomycin and josamycin. Acta Gynecol Scand 2000; 79: 234–7.
24. Solitz-Szots J, Schneider S, Niebauer B et al. [Significance of the dose of josamycin in the treatment of chlamydia infected pregnant patients]. Z Hautkr 1989; 64: 129–31.
25. Седых Н.Н. Этические гарантии доказанности клинических испытаний. Биоэтика. 2008; 1: 16–21.
26. Heikkinen T, Laine K, Neuvonen PJ, Ekblad U. The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. BJOG 2000; 107: 770–5.
27. McCormack WM, George H, Donner A. Hepatotoxicity of erythromycin estolate during pregnancy. AntiMicrob Agents Chemother 1977; 12: 630–5.
28. Kallen BAJ, Otterblad Olausson P, Danielsson BR. Is erythromycin therapy teratogenic in humans? Reprod Toxicol 2005; 20: 209–14.
29. Volberg WA, Koci BJ, Su W et al. Blockade of human cardias potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics. J Pharmacol Exp Ther 2002; 302: 320–7.
30. Dylewski J, Clecner B, Dubois J et al. Comparison of spiramycin and doxycycline for treatment of Chlamydia trachomatis genital infections. Antimicrob Agents Chemother 1993; 37 (6): 1373–4.
31. Fedele L, Acaia B, Marchini M et al. Treatment of Chlamydia trachomatis endometritis with josamycin. J Chemother 1989; 1 (4 Suppl.): 911–2.
32. Решетников О.В., Хрянин А.А. Макролиды в лечении хламидийной инфекции у беременных (эффективность, безопасность, экономичность). Рус. мед. журн. 2008; 16: 23–7.
33. Khrianin AA, Reshetnikov OV. Is it safe to use josamycin in the obstetrics practice in Russia? Antibiot Khimioter 2007; 52: 32–6.
34. Charles P, Stumpf P, Buffet P et al. Two unusual glandular presentations of tick-borne tularemia. Med Mal Infect 2008; 8: 159–61.
35. Юрьев С.Ю., Евтушенко И.Д., Огородова Л.М. Определение концентрации азитромицина в хориальной ткани в I триместре беременности. Антибиот. и химиотер. 2004; 49: 10–2.
36. Ramsey PS, Vaules MB, Vasdev GM et al. Maternal and transplacental pharmacokinetics of azithromycin. Am J Obstet Gynecol 2003; 188: 714–8.
37. Jacobson GF, Autry AM, Kirby RS et al. A randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy. Am J Obstet Gynecol 2001; 184: 1352–4.
38. Edwards MS, Newman RB, Carter SG et al. Randomized clinical trial of azithromycin vs erythromycin for the treatment of Chlamydia cervicitis in pregnancy. Infect Dis Obstet Cynecol 1997; 4: 333–7.
39. Sarkar M, Woodland CC, Koren G, Einarson ARN. Pregnancy outcome following gestational exposure to azithromycin. BMC Pregnancy Childbirth 2006; 6: 18.
40. Brockleburst P, Rooney G. Interventions for treating genital Chlamydia trachomatis infection in pregnancy (Cocbrane Review). In: The Cocbrane Library, Issue 3, 2004. Chicbester, UK: John Wiley & Sons, Ltd.
41. Miller JM, Martin DH. Treatment of Chlamydia trachomatis infections in pregnant women. Drugs 2000; 60 (3): 597–605.
42. Kacmar J, Cheh E, Montagno A, Peipert JF. A randomized trial of azithromycin versus amoxicillin for the treatment of Chlamydia trachomatis in pregnancy. Infect Dis Obstet Gynecol 2001; 9: 197–202.
43. Gunter ME, Adair CD, Ernest JM, McElroy G. Azithromycin powder versus erythromycin in the treatment of chlamydial cervicitis in pregnancy. Infect Dis Obstet Gynecol 1996; 4: 53.
44. Adair CD, Gunter M, Stovall TG et al. Chlamydia in pregnancy: a randomized trial of azithromycin and erythromycin. Obstet Gynecol 1998; 91: 165–8.
________________________________________________
2. Mayand P, Mabey D. Approaches to the control of sexually transmitted infections in developing countries: old problems and modern challenges. Sex Trans Inf 2004; 80: 174–82.
3. Hueston WJ, Lenhart JG. A decision analysis to guige antibiotis selection for Chlamydia infection during pregnancy. Arch Fam Med 1997; 6: 551–5.
4. Centers for disease and prevention. Sexually transmitted disease surveillance 2003 supplement. Atlanta, GA; CDC, 2004.
5. Advanced Fertility Center of Chicago. http://www.advancedfertility.com/ectopic.htm[accessed 9 May 2007].
6. Woman at the Rise of the 21st Centry: Gynecological and Reproductine issues in Health and Diseases. Conference proceadings. Athens, Greece,Vovember 18–21, 1998. Ann NY Acad Sci 2000; 900: 1–446.
7. Grossman JH, Rivein ME, Morrison JC. Diagnosis of Chlamydial infection in pregnant women using the Testpack Chlamydia diagnostic kit. Obstet Gynecol 1991; 77: 801–3.
8. Andrews WN, Goldenferd RL, Mercer B et al. The Preterm Prediction Study: association of second-trimester genitourinary Chlamydia infection with subsequent spontaneous preterm birth. Am J Obstet Gynecol 2000; 183: 662–8 (Abstract).
9. Fiest A, Sydier T, Gebbers SS et al. No association of Chlamydia with abortion. J Soc Med 1999; 92 (5): 237–8.
10. Miller JM, Martin DH. Treatment of Chlamydia trachomatis infections in pregnant women. Drugs 2000; 60 (3): 597–605.
11. Centers for Disease Control and Prevention. Sexyally Transmitted Diseases Treatment Quidelines-2002. MMWR Morb Mortal Wkly Rep 2002; 51: 1–80.
712. Национальные стандарты в здравоохранении: перспективы разработки и внедрения. Врач 2008. Спец. вып: 2–60.
13. Стандарты медицинской помощи больным урогенитальными инфекциями. Врач. 2009; 1: 36–67.
14. Клинические рекомендации. Российское общество дерматовенерологов. Дерматовенерология. Под ред. А.А.Кубановой. М.: ДЭКС-Пресс, 2008.
15. Клинические рекомендации. Акушерство и гинекология. Под ред. В.Н.Серова, Г.Т.Сухих. 3-е изд. М.: ГОЭТАР-Медиа, 2009.
16. Рациональная фармакотерапия в акушерстве, гинекологии и неонатологии. Под ред. В.Н.Серова, Г.Т.Сухих. М.: Литтерра, 2010.
17. Harris RP, Hefland M, Woolf SH et al. Current methods of the us preventive services task force: a revin of the process. Am J Prev Med 2001; 20 (suppl.): 21–35.
18. Andrade SE, Gurwitz JM, Davis RL et al. Prescription drug use in pregnany. Am J Obstet Gynecol 2004; 191: 398–407.
19. Guidelines for the management of sexually transmitted infections, World Health Organization, 2003.
20. Европейские стандарты диагностики и лечения заболеваний, передаваемых половым путем. М.: Медицинская литература, 2003.
21. Center for Disease Control and Prevention. Guidelines for treatment of sexually transmitted diseases. MMWR 2006.
22. http://www.iusti.org Draft European (IUSTI/WHO) for the management of Chlamydia trachomatis infections.
23. Czeizel AE, Rockenbauer M, Olsen J, Sorensen HT. A case-control teratological study of spiramycin, roxitromycin, oleandomycin and josamycin. Acta Gynecol Scand 2000; 79: 234–7.
24. Solitz-Szots J, Schneider S, Niebauer B et al. [Significance of the dose of josamycin in the treatment of chlamydia infected pregnant patients]. Z Hautkr 1989; 64: 129–31.
25. Седых Н.Н. Этические гарантии доказанности клинических испытаний. Биоэтика. 2008; 1: 16–21.
26. Heikkinen T, Laine K, Neuvonen PJ, Ekblad U. The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. BJOG 2000; 107: 770–5.
27. McCormack WM, George H, Donner A. Hepatotoxicity of erythromycin estolate during pregnancy. AntiMicrob Agents Chemother 1977; 12: 630–5.
28. Kallen BAJ, Otterblad Olausson P, Danielsson BR. Is erythromycin therapy teratogenic in humans? Reprod Toxicol 2005; 20: 209–14.
29. Volberg WA, Koci BJ, Su W et al. Blockade of human cardias potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics. J Pharmacol Exp Ther 2002; 302: 320–7.
30. Dylewski J, Clecner B, Dubois J et al. Comparison of spiramycin and doxycycline for treatment of Chlamydia trachomatis genital infections. Antimicrob Agents Chemother 1993; 37 (6): 1373–4.
31. Fedele L, Acaia B, Marchini M et al. Treatment of Chlamydia trachomatis endometritis with josamycin. J Chemother 1989; 1 (4 Suppl.): 911–2.
32. Решетников О.В., Хрянин А.А. Макролиды в лечении хламидийной инфекции у беременных (эффективность, безопасность, экономичность). Рус. мед. журн. 2008; 16: 23–7.
33. Khrianin AA, Reshetnikov OV. Is it safe to use josamycin in the obstetrics practice in Russia? Antibiot Khimioter 2007; 52: 32–6.
34. Charles P, Stumpf P, Buffet P et al. Two unusual glandular presentations of tick-borne tularemia. Med Mal Infect 2008; 8: 159–61.
35. Юрьев С.Ю., Евтушенко И.Д., Огородова Л.М. Определение концентрации азитромицина в хориальной ткани в I триместре беременности. Антибиот. и химиотер. 2004; 49: 10–2.
36. Ramsey PS, Vaules MB, Vasdev GM et al. Maternal and transplacental pharmacokinetics of azithromycin. Am J Obstet Gynecol 2003; 188: 714–8.
37. Jacobson GF, Autry AM, Kirby RS et al. A randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy. Am J Obstet Gynecol 2001; 184: 1352–4.
38. Edwards MS, Newman RB, Carter SG et al. Randomized clinical trial of azithromycin vs erythromycin for the treatment of Chlamydia cervicitis in pregnancy. Infect Dis Obstet Cynecol 1997; 4: 333–7.
39. Sarkar M, Woodland CC, Koren G, Einarson ARN. Pregnancy outcome following gestational exposure to azithromycin. BMC Pregnancy Childbirth 2006; 6: 18.
40. Brockleburst P, Rooney G. Interventions for treating genital Chlamydia trachomatis infection in pregnancy (Cocbrane Review). In: The Cocbrane Library, Issue 3, 2004. Chicbester, UK: John Wiley & Sons, Ltd.
41. Miller JM, Martin DH. Treatment of Chlamydia trachomatis infections in pregnant women. Drugs 2000; 60 (3): 597–605.
42. Kacmar J, Cheh E, Montagno A, Peipert JF. A randomized trial of azithromycin versus amoxicillin for the treatment of Chlamydia trachomatis in pregnancy. Infect Dis Obstet Gynecol 2001; 9: 197–202.
43. Gunter ME, Adair CD, Ernest JM, McElroy G. Azithromycin powder versus erythromycin in the treatment of chlamydial cervicitis in pregnancy. Infect Dis Obstet Gynecol 1996; 4: 53.
44. Adair CD, Gunter M, Stovall TG et al. Chlamydia in pregnancy: a randomized trial of azithromycin and erythromycin. Obstet Gynecol 1998; 91: 165–8.
Авторы
В.И.Кисина
Первый МГМУ им. И.М.Сеченова (ректор – член-кор. РАМН, проф., П.В.Глыбочко)
Первый МГМУ им. И.М.Сеченова (ректор – член-кор. РАМН, проф., П.В.Глыбочко)
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.